It was great to connect at #ISPOREurope! Thank you to everyone who joined our presentations, engaged with us at the poster sessions, and visited our booth for a demo. If you missed us in Barcelona and would like to get in touch with us, you can contact us here: https://hubs.li/Q02Z2ZJ60 Until next time!
关于我们
Aetion is a health care analytics company that delivers real-world evidence for the manufacturers, purchasers, and regulators of medical treatments and technologies. The Aetion Evidence Platform? analyzes data from the real world to produce transparent, rapid, and scientifically validated answers on safety, effectiveness, and value. Founded by Harvard Medical School faculty members with decades of experience in epidemiology and health outcomes research, Aetion informs health care’s most critical decisions — what works best, for whom, and when — to guide product development, commercialization, and payment innovation. Aetion is based in New York City and backed by investors including New Enterprise Associates (NEA), Warburg Pincus, Flare Capital Partners, Greenspring Associates, Lakestar, B Capital, Foresite Capital, Town Hall Ventures, McKesson Ventures, Sanofi Ventures, EDBI, Johnson & Johnson Innovation—JJDC, Inc., UCB, Amgen Ventures, and Horizon Health Services, Inc. Learn more at aetion.com and follow us at @aetioninc.
- 网站
-
https://aetion.com
Aetion的外部链接
- 所属行业
- 软件开发
- 规模
- 201-500 人
- 总部
- New York，NY
- 类型
- 私人持股
- 创立
- 2012
地点
Aetion员工
动态
-
See you at #ISPOREurope! Be sure to visit our poster sessions throughout the event and connect with our #ATeam to learn more about this important work. https://hubs.li/Q02WFTBG0 Monday, November 18: ? Use of Real-World Evidence to Support Regulatory Clearance of a Labeling Revision for Robotic-Assisted Radical Prostatectomy in the United States Tuesday, November 19: ? Identifying Fit-for-Emulation Data: Adaptation of a Structured Data Feasibility Assessment Process for Real-World Oncology Trial Emulations ? Use of Real-World Evidence in Health Technology Reassessments Across Six Health Technology Assessment Agencies ? Augmenting External Control Arms Using Synthetic Data Generation
-
-
Aetion's Commercial Product Lead for Scientific Services & HEOR Markets, Ashley Jaksa, started off #ISPOREurope with a bang today at the Real-World Evidence Summit. Our A-Team is just getting warmed up, so be sure to also catch our scientists in action during our live presentations and poster sessions. You can also stop by and chat with our experts at Booth 1212 or set up a meeting in advance: https://hubs.li/Q02YsCRk0
-
-
The FDA will hold a free public workshop on December 12, 2024, to explore recent progress and future goals for its #RealWorldEvidence (RWE) Program. Hosted with the Duke-Margolis Institute for Health Policy, this hybrid event will discuss #RWE's potential in advancing #DrugDevelopment and regulatory clarity. At Aetion, we’re excited to see the FDA’s commitment to integrating RWE in regulatory frameworks and look forward to supporting this evolution. More info here: https://hubs.li/Q02Y4N3K0
-
Exploring patient subgroups shouldn’t be a bottleneck. With Aetion? Discover, you can instantly explore and analyze subgroups to reveal critical insights faster. Our intuitive, visual-first platform makes it easy to uncover insights quickly and confidently, empowering your team to answer complex research questions and drive better healthcare decision-making. See how Discover can transform your approach to real-world data by stopping by Booth 1212 at #ISPOREurope or schedule a meeting in advance: https://hubs.li/Q02Ydv6p0 #RWD #DataVisualization #HealthcareInnovation #AetionDiscover
-
We're off to Barcelona for #ISPOREurope and we can’t wait to see you there! Visit our #RWD experts at booth 1212 or schedule a meeting in advance using this link: https://hubs.li/Q02WFG2S0 Be sure to also catch our #ATeam of scientists in action during our live presentations and poster sessions.
-
-
Attending #ISPOREurope? We encourage you to see Aetion's research on display and stop by our poster sessions on Monday, November 18th and Tuesday, November 19th! Interested in connecting with our scientists to learn more about this important work? Stop by Booth 1212 or schedule a meeting in advance: https://hubs.li/Q02WFGdR0
-
-
Aetion转发了
Kevin Riley, President of Aetion, sits down with Nasdaq's Kristina Ayanian to discuss Aetion's mission to power critical decisions in healthcare with data science-driven technology. Watch more: https://lnkd.in/gwZQr74D
-
Join Ulka Campbell (Head of Scientific Strategy at Aetion) on Tuesday, November 19 from 10:15 a.m. - 11:15 a.m. CET where she will be part of the panel discussion, “Comparing and Contrasting RWE Guidance: What Researchers Need to Know Considering the Global Picture.” Don't miss this insightful session on recent regulatory guidance for #RWE, with a focus on #RWD quality. The panel will also cover differences and similarities across agencies, offering insights on how researchers can navigate and harmonize these guidelines. See Aetion's full schedule here: https://hubs.li/Q02WFSk50
-
-
During its recent Nexus conference, the Academy of Managed Care Pharmacy (AMCPorg) discussed the importance of using #RealWorldEvidence (RWE) in healthcare decisions and set a goal to bring manufacturers and payers together to drive RWE adoption. Read more from the panel session: https://hubs.li/Q02XW0jy0 At Aetion, we’re true believers in the power of RWE, and we’ve developed a suite of applications that put it to work to support critical decisions on safety, effectiveness, and value in the real world. https://hubs.li/Q02XVLlG0
-